Versant Vantage II GP-GP, LLC insider trades
Versant Vantage II GP-GP, LLC has filed 4 Form 4s with the SEC that we hold, all for LENZ Therapeutics, Inc. (LENZ), as 10% owner. Across all of them we count 1 purchase worth $3.1M and 8 sales worth $26.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 350,000 shares of LENZ Therapeutics, Inc. worth $10.2M, dated 2025-06-10. The first filing on our record is dated 2021-07-01 and the latest 2025-10-02.
LENZ Therapeutics, Inc. (LENZ)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-06-29 | P, purchase reported on Form 4 | 180,000 | $3.1M | 2021-07-01 |
| 2025-06-10 | S, sale reported on Form 4 | 350,000 | $10.2M | 2025-06-12 |
| 2025-06-27 | S, sale reported on Form 4 | 200,000 | $6.1M | 2025-07-01 |
| 2025-09-30 | S, sale reported on Form 4 | 34,405 | $1.6M | 2025-10-02 |
| 2025-09-30 | S, sale reported on Form 4 | 49,701 | $2.3M | 2025-10-02 |
| 2025-09-30 | S, sale reported on Form 4 | 83,066 | $3.9M | 2025-10-02 |
| 2025-09-30 | S, sale reported on Form 4 | 57,502 | $2.7M | 2025-10-02 |
| 2025-09-30 | S, sale reported on Form 4 | 177 | $8.3K | 2025-10-02 |
| 2025-09-30 | S, sale reported on Form 4 | 123 | $5.8K | 2025-10-02 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1839789) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms